Clinical Trial Update: Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non Erosive Reflux Disease [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of DWP14012 in patients with non-erosive gastroesophageal reflux disease; status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-erosive Gastroesophageal Reflux Disease

Drugs mentioned

• DWP14012

Snippet

Sponsor: Daewoong Pharmaceutical Co. LTD. | Conditions: Non-Erosive Gastroesophageal Reflux Disease | Phase 3 | Status: UNKNOWN